Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Dow
McKinsey
Colorcon
US Department of Justice
Fuji
Federal Trade Commission
Baxter
Julphar

Generated: November 16, 2018

DrugPatentWatch Database Preview

Nucleoside Metabolic Inhibitor Drug Class List

« Back to Dashboard

Drugs in Drug Class: Nucleoside Metabolic Inhibitor

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharms Corp ARRANON nelarabine INJECTABLE;INTRAVENOUS 021877-001 Oct 28, 2005 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Institutional AZACITIDINE azacitidine POWDER;INTRAVENOUS, SUBCUTANEOUS 204949-001 Apr 28, 2016 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Shilpa Medicare AZACITIDINE azacitidine POWDER;INTRAVENOUS, SUBCUTANEOUS 207518-001 Sep 29, 2016 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Natco Pharma Ltd AZACITIDINE azacitidine POWDER;INTRAVENOUS, SUBCUTANEOUS 207234-001 Jun 23, 2017 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cipla Ltd AZACITIDINE azacitidine POWDER;INTRAVENOUS, SUBCUTANEOUS 209540-001 May 4, 2018 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
QuintilesIMS
Covington
Deloitte
Cipla
Cerilliant
McKesson
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.